Sander Dale A.'s most recent trade in Humacyte Inc was a trade of 20,000 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on April 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Purchase of securities on an exchange or from another person at price $ 1.53 per share. | 10 Apr 2025 | 20,000 | 40,600 | - | 1.5 | 30,600 | Common Stock |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 283,101 | 283,101 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 525 | 2,625 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share. | 27 Aug 2024 | 39,389 | 41,389 | - | 2.6 | 100,836 | Common Stock |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 39,389 | 0 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Sale of securities on an exchange or to another person at price $ 6.68 per share. | 27 Aug 2024 | 39,389 | 2,000 | - | 6.7 | 263,119 | Common Stock |
| Humacyte Inc | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 301,000 | 301,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 525 | 2,100 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 13 Dec 2022 | 20,000 | 20,600 | - | 2.6 | 52,000 | Common Stock |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | 13 Dec 2022 | 600 | 600 | - | 0 | Common Stock | ||
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 136,000 | 136,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Purchase of securities on an exchange or from another person at price $ 4.53 per share. | 17 May 2022 | 2,000 | 2,000 | - | 4.5 | 9,060 | Common Stock |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 210,077 | 210,077 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 183,817 | 183,817 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 39,389 | 39,389 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,068 | 17,068 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Dale A. Sander | CFO and Chief Corp. Deve. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,575 | 1,575 | - | - | Stock Options (right to buy) |